The Institute of Medicine (IOM) of the National Academies of Sciences, Engineering and Medicine has released the report, “Eliminating the Public Health Problem of Hepatitis B and C in the United States,” which explores the barriers that must be overcome to eliminate hepatitis B and hepatitis C in the United States. Commissioned by the Office of Minority Health at HHS and the Division of Viral Hepatitis at CDC, the IOM was charged with determining whether elimination goals for hepatitis B and hepatitis C in the United States are feasible and identifying possible critical success factors. The report reaffirms that hepatitis elimination can be achieved with the right resources, commitment, and strategy.

In the face of recent developments in hepatitis C treatment, enhanced global solidarity for hepatitis B and hepatitis C elimination goals, and progress implementing The Action Plan for the Prevention, Care, & Treatment of Viral Hepatitis 2014-2016, an ambitious strategy to set and achieve hepatitis B virus and hepatitis C virus elimination goals in the United States is needed. An expert committee examined scientific and policy issues related to the prevention, detection, control, and management of hepatitis B virus and hepatitis C virus. Learn more and view the report